FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “MANAGE MYCOPHENOLATE AWARENESS NETWORK: ASSISTANCE, GUIDANCE AND EDUCATION”, which is offered here for Booklets in the field of providing educational information to healthcare providers and female patients of childbearing potential of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks;color is not claimed as a feature of the mark.;administering a regulatory compliance program in the field of prescription medicine to prevent unplanned pregnancy and to provide pregnancy planning, thereby seeking to minimize and limit fetal exposure by informing healthcare providers and female patients of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks;providing educational information to healthcare providers and female patients of childbearing potential of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks via an internet website; maintaining a pregnancy registry for the purpose of documenting maternal and fetal outcomes in order to further characterize the risk of mycophenolate mofetil (mmf) / mycophenolic acid (mpa) fetal exposure;mycophenolate awareness network;.
Its status is currently believed to be active. Its class is unavailable. “MANAGE MYCOPHENOLATE AWARENESS NETWORK: ASSISTANCE, GUIDANCE AND EDUCATION” is believed to be currently owned by “HOFFMANN-LA ROCHE INC.”
Owner: |
HOFFMANN-LA ROCHE INC.
Owner Details |
---|---|
Description: |
Booklets in the field of providing educational information to healthcare providers and female patients of childbearing potential of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks;Color is not claimed as a feature of the mark.;administering a regulatory compliance program in the field of prescription medicine to prevent unplanned pregnancy and to provide pregnancy planning, thereby seeking to minimize and limit fetal exposure by informing healthcare providers and female patients of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks;providing educational information to healthcare providers and female patients of childbearing potential of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks via an Internet website; maintaining a pregnancy registry for the purpose of documenting maternal and fetal outcomes in order to further characterize the risk of mycophenolate mofetil (MMF) / mycophenolic acid (MPA) fetal exposure;MYCOPHENOLATE AWARENESS NETWORK;
|
Categories: | BOOKLETS FIELD |